Predictors of Relapse and Treatment Response in Patients With AQP4-IgG–Positive and Seronegative NMOSD
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of Neurology, Neurosurgery, and Psychiatry
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Predictors of relapse risk and treatment response in AQP4-IgG positive and seronegative NMOSD: A multicentre study
J. Neurol. Neurosurg. Psychiatr. 2024 Sep 04;[EPub Ahead of Print], P Siriratnam, P Sanfilippo, A van der Walt, S Sharmin, YC Foong, WZ Yeh, C Zhu, SJ Khoury, T Csepany, B Willekens, M Etemadifar, S Ozakbas, P Nytrova, A Altintas, A Al-Asmi, B Yamout, G Laureys, F Patti, M Simo, A Surcinelli, M Foschi, PA McCombe, R Alroughani, JL Sánchez-Menoyo, R Turkoglu, A Soysal, J Lechner Scott, T Kalincik, H Butzkueven, V Jokubaitis, S Huda, M MonifFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.